Nanhua Bio (China) Market Value
| 000504 Stock | 10.42 0.15 1.46% |
| Symbol | Nanhua |
Nanhua Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nanhua Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nanhua Bio.
| 08/31/2024 |
| 11/29/2024 |
If you would invest 0.00 in Nanhua Bio on August 31, 2024 and sell it all today you would earn a total of 0.00 from holding Nanhua Bio Medicine or generate 0.0% return on investment in Nanhua Bio over 90 days. Nanhua Bio is related to or competes with StarPower Semiconductor, Jiangxi Naipu, GRINM Semiconductor, Nexchip Semiconductor, Jonjee Hi-tech, Tibet Huayu, and Qingdao Choho. More
Nanhua Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nanhua Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nanhua Bio Medicine upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.69 | |||
| Information Ratio | 0.1166 | |||
| Maximum Drawdown | 19.08 | |||
| Value At Risk | (5.67) | |||
| Potential Upside | 9.82 |
Nanhua Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nanhua Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nanhua Bio's standard deviation. In reality, there are many statistical measures that can use Nanhua Bio historical prices to predict the future Nanhua Bio's volatility.| Risk Adjusted Performance | 0.1201 | |||
| Jensen Alpha | 0.5934 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.1345 | |||
| Treynor Ratio | 3.74 |
Nanhua Bio Medicine Backtested Returns
Nanhua Bio appears to be slightly risky, given 3 months investment horizon. Nanhua Bio Medicine has Sharpe Ratio of 0.15, which conveys that the firm had a 0.15% return per unit of risk over the last 3 months. By analyzing Nanhua Bio's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please exercise Nanhua Bio's Risk Adjusted Performance of 0.1201, mean deviation of 3.39, and Downside Deviation of 3.69 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Nanhua Bio holds a performance score of 11. The company secures a Beta (Market Risk) of 0.16, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Nanhua Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nanhua Bio is expected to be smaller as well. Please check Nanhua Bio's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether Nanhua Bio's current price movements will revert.
Auto-correlation | 0.01 |
Virtually no predictability
Nanhua Bio Medicine has virtually no predictability. Overlapping area represents the amount of predictability between Nanhua Bio time series from 31st of August 2024 to 15th of October 2024 and 15th of October 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nanhua Bio Medicine price movement. The serial correlation of 0.01 indicates that just 1.0% of current Nanhua Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.64 |
Nanhua Bio Medicine lagged returns against current returns
Autocorrelation, which is Nanhua Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nanhua Bio's stock expected returns. We can calculate the autocorrelation of Nanhua Bio returns to help us make a trade decision. For example, suppose you find that Nanhua Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nanhua Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nanhua Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nanhua Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nanhua Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Nanhua Bio Lagged Returns
When evaluating Nanhua Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nanhua Bio stock have on its future price. Nanhua Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nanhua Bio autocorrelation shows the relationship between Nanhua Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Nanhua Bio Medicine.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.